title: Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample.
authors.forename: M
authors.initials: M
authors.lastname: Dettling
authors.forename: I
authors.initials: I
authors.lastname: Cascorbi
authors.forename: I
authors.initials: I
authors.lastname: Roots
authors.forename: B
authors.initials: B
authors.lastname: Mueller-Oerlinghausen
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced* / Q000235:genetics*; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006683:HLA-DQ Antigens / Q000235:genetics; D059866:HLA-DQ beta-Chains; D006684:HLA-DR Antigens / Q000235:genetics; D059845:HLA-DRB4 Chains; D006650:Histocompatibility Testing; D006801:Humans; D007585:Jews / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D010597:Pharmacogenetics; D012559:Schizophrenia / Q000188:drug therapy*; D044465:White People / Q000235:genetics*
chemical_list: D006683:HLA-DQ Antigens; D059866:HLA-DQ beta-Chains; C057615:HLA-DQbeta antigen; D006684:HLA-DR Antigens; D059845:HLA-DRB4 Chains; D003024:Clozapine